Indonesia National AIDS Spending Assessment 2011-2012. Nadjib M, Megraini A, Ishardini L and Rosalina L. (2013)

immage

HIV and AIDS are among health issues prioritized in the Millenium Development Goals (MDGs) and require considerable attention from various stakeholders. The Government of Indonesia, along with international partners has been working hard in suppressing the spread of AIDS in the country through various programs. However, more challenges remain, and despite considerable amount of money spent in resources to combat HIV and AIDS in Indonesia, the rate of new cases of HIV continue to persist.

 

Keywords: NASA, expenditures, spending, prevention, treatment, vulnerable

Download Publication

Transaction Prices for Antiretroviral Medicines from 2010 to 2013: WHO AIDS Medicines and Diagnostics Services: Global Price Reporting Mechanism: Summary Report. WHO. (2013)

immage

This summary report is intended to provide the pricing data of key ARVs to governments, nongovernmental organizations, donors, international organizations, academia and individuals or institutions directly involved or interested in the procurement of ARVs in resource-poor settings.


Keywords: HIV, drug, economics, infections, therapy

Download Publication

Evaluation of a Decade of DFID and World Bank Supported HIV and AIDS Programmes in Vietnam from 2003 to 2012. Zhang L, Maher L, Pham QD, et al. (2013)

immage

This report provides the findings of a comprehensive evaluation on the implementation, management, estimated population impacts, and cost-effectiveness of the DFID and the World Bank funded harm reduction programmes in Vietnam. It mainly included three major components: (1) an extensive literature review of legal and policy documents to understand key changes in the legal and policy environment in Vietnam; (2) a qualitative study utilising focus groups with key stakeholders and programme participants to provide background and context for understanding the implementation, management and effectiveness of the DFID/WB programmes; (3) a quantitative assessment of population impacts and cost-effectiveness of DFID/WB programmes based on a mathematical model.

Download Publication

Return on Investment and Cost-Effectiveness of Harm Reduction Programme in Malaysia. Naning H, Kerr C, Kamarulzaman A, et al. (2013)

immage

This project aimed to assess whether the harm reduction programme in Malaysia, which consists of NSP and MMT programmes amongst PWID, have been cost-effective from the perspective of the government by estimating savings in direct health care cost to the government resulting from infections that were averted as a result of the NSP and MMT programmes. The following estimates were included in the estimate of savings in direct health care costs; estimate the cost-effectiveness of the NSP and MMT programmes in terms of costs for the provision of programmes net of health care cost savings for each quality-adjusted-life years (QALYs) gained; estimate the return on investment (ROI) from NSP and MMT programmes where ROI refers to total health care costs saved from averted infections in comparison to total programme costs.


Keywords: HIV, AIDS, needles, syringes, PWID, estimates, infections

Download Publication

National AIDS Spending Assessment (NASA IV) in Cambodia: Years of Assessment: 2011 and 2012. Nitsoy A. (2013)

immage

NASA team always aims to collect expenditure data from all actors of the response. These organizations – actors of the HIV response – are playing different roles in different transactions, either financial or in-kind. The organization acts as a Financing Source when it makes money available for the country’s HIV response. It transfers funds to the other organizations who decide what should be implemented and who will be implementing. This role is a role of a Financing.

Download Publication

Strategic Investments for Impact: Global Fund Results Report 2012. The Global Fund (2012)

Strategic Investments_for_Impact_Global_Fund_Results_Report_2012

The Global Fund Results Report 2012 presents the latest data from recipients of Global Fund grants in 151 countries – as well as the latest evidence of impact on the HIV, tuberculosis (TB) and malaria pandemics, and the most up-to-date information on Global Fund financing. It highlights the continued progress and the scale-up achieved by low- and middle-income countries around the world, made possible by the collaboration and efforts of hundreds of governments, donors, recipients, technical agencies, private companies and civil society organizations.

 

 

 

Download this publication

2012 National AIDS Spending Assessment In-Country Exercise. Ravuci L, Seva M, Rokovunisei M, et al. (2012)

immage

The Fiji Government, via the National HIV Board, is pursuing a robust initiative to capture strategic information regarding the national response to HIV & AIDS vis-à-vis the tracking of financial information from financing sources to actual expenditures.
The National HIV Board continues to understand and promote the importance of the National AIDS Spending Assessment methodology as it provides a platform to influence decision making in terms of future resource allocations in the HIV & AIDS response.

 

Keywords: HIV response, NASA, financing, prevention, care, treatment, PLHIV, most at risk populations

 

Download Publication

China National AIDS Spending Assessment 2010. Yakusik A, Zhongdan C, Fernández CA, et al. (2012)

immage

Comprehensive information about national spending on AIDS response is crucial for health policy development and evaluation. Dehong Prefecture of Yunnan Province is one of the areas hardest hit by HIV in China. Since 1989, when the first 146 HIV-infected injecting drug users (IDUs) were identified in Dehong, this area with 1.1 million of people reported a cumulative total of 17,590 HIV cases by the end of 2010. Studies conducted suggest that the population prevalence for HIV infections in Dehong Prefecture is estimated to be 1.3%. IDUs make up the majority of the people living with HIV (PLHIV) in Dehong Prefecture, accounting for more than a half of the total number of estimated HIV cases in Dehong with high estimated HIV prevalence. HIV transmission mode has been changing gradually over the recent years from intravenous drug use to heterosexual and homosexual transmission. This study provides a comprehensive overview of the overall level and composition of major investments in national AIDS response in Dehong Prefecture introducing National AIDS Spending Assessment (NASA) as a method for the purpose.


Keywords: HIV/AIDS, cases, death, mode of transmission, investments, funding

Download Publication

Indonesia National AIDS Spending Assessment 2011-2012. Nadjib M, Megraini A, Ishardini L and Rosalina L. (2013)

immage

HIV and AIDS are among health issues prioritized in the Millenium Development Goals (MDGs) and require considerable attention from various stakeholders. The Government of Indonesia, along with international partners has been working hard in suppressing the spread of AIDS in the country through various programs. However, more challenges remain, and despite considerable amount of money spent in resources to combat HIV and AIDS in Indonesia, the rate of new cases of HIV continue to persist.

 

Keywords: NASA, expenditures, spending, prevention, treatment, vulnerable

Download Publication

Sri Lanka: National AIDS Spending Assessment 2009-2010. Colombo, Institute for Health Policy and National STD/AIDS Control Programme Ministry of Health (2012)

Sri Lanka_National_AIDS_Spending_Assessment

Tracking of national HIV expenditures and financing flows are an essential requirement to monitor and plan the resources for tackling HIV. The National AIDS Spending Assessment (NASA) tool, assists to monitor these scarce resources for HIV, considering not just the health components, but also education, social protection services, and others, in order to evaluate and quantify the multi-sectoral approach of the national AIDS response. NASA will help to identify funding gaps and duplication of funding in the national response to HIV epidemic.

This publication provides estimates of overall HIV spending in the country for the years 2009–2010, and will be of much value to the Ministry of Health (MOH), as well as the stakeholders who are interested in understanding the financial flows of the national AIDS response.

 

 

 

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)